The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care

Frontiers in Neurology

Volumn 4 APR, Issue , 2013, Pages

  Kochanek, Patrick M ^a   Berger, Rachel P ^b   Fink, Ericka L ^b   Au, Alicia K ^b   Bayir, Hülya ^a,b,c   Bell, Michael J ^a,b   Dixon, C Edward ^a,c   Clark, Robert S B ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Abusive head trauma; Cerebrospinal fluid; GFAP; Myelin basic protein; Neuron specific enolase; S100 ; Shaken baby syndrome; UCH L1

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CASPASE 3; CORTICOSTEROID; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; KETAMINE; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PLACEBO; PROTEIN BCL 2; PROTEIN S100B; TAU PROTEIN;

ARTICLE; AXONAL INJURY; CARDIOPULMONARY BYPASS; CHILD ABUSE; EXCITOTOXICITY; EXTRACORPOREAL OXYGENATION; HEAD INJURY; HEART ARREST; HUMAN; HYDROCEPHALUS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PATIENT MONITORING; PROGNOSIS; RESPIRATORY FAILURE; SEPTIC SHOCK; TRAUMATIC AXONAL INJURY; TRAUMATIC BRAIN INJURY;

EID: 84878811361     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00040     Document Type: Article

References (85)

1. Abdul-Khaliq, H., Schubert, S., Fischer, T., Bottcher, W., Harke, C., Alexi-Meskishvili, V., et al. (2000). The effect of continuous treatment with sodium nitroprusside on the serum kinetics of the brain marker protein S-100beta in neonates undergoing corrective cardiac surgery by means of hypothermic cardiopulmonary bypass. Clin. Chem. Lab. Med. 38, 1173-1175.
2. Adamczak, S., Dale, G., de Rivero Vaccari, J. P., Bullock, M. R., Deitrich, W. D., and Keane, R. W. (2012). Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome. J. Neurosurg. 117, 1119-1125.
3. Ali, M. S., Harmer, M., and Vaughan, R. (2000). Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br. J. Anaesth. 85, 287-298.
4. Amick, J. E., Yandora, K. A., Janesko-Feldman, K. L., Adelson, P. D., Ruppel, R. A., Clark, R. S. B., et al. (2001). TH1 versus TH2 cytokine profiles in cerebrospinal fluid after severe traumatic brain injury in children. Pediatr. Crit. Care Med. 2, 260-264.
5. Au, A. K., Aneja, R. J., Bell, M. J., Bayir, H., Feldman, K., Adelson, P. D., et al. (2012). Cerebrospinal fluid levels of high mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. J. Neurotrauma 29, 2013-2021.
6. Babikan, T., Freier, M. C., Tong, K. A., Nickerson, J. P., Wall, C. J., Holshouser, B. A., et al. (2005). Susceptibility weighted imaging: neuropsychologic outcome and pediatric head injury. Pediatr. Neurol. 33, 184-194.
7. Bayir, H., Adelson, P. D., Wisniewski, S. R., Shore, P. M., Lai, Y. C., Brown, S. D., et al. (2009). Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. Crit. Care Med. 37, 1536.
8. Bayir, H., Kagan, V. E., Tyurina, Y. Y., Tyurin, V. A., Rupel, R. A., Adelson, P. D., et al. (2002). Assessment of antioxidant reserve and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr. Res. 51, 571-578.
9. Bayir, H., Tyurin, V. A., Tyurin, Y. Y., Veiner, R., Ritov, V., Amoscato, A., et al. (2007). Selective early cardiolipin oxidation after brain trauma: a lipidomics analysis. Ann. Neurol. 62, 154-169.
10. Bell, M., Adelson, P. D., Doughty, L. A., Carcillo, J. A., Clark, R. S. B., DeKosky, S., et al. (1997a). Comparison of the interleukin-6 and interleukin-10 response in children after severe traumatic brain injury or septic shock. Acta. Neurochir. Suppl. 70, 96-97.
11. Bell, M., Kochanek, P. M., Doughty, L. A., Carcillo, J. A., Adelson, P. D., Clark, R. S. B., et al. (1997b). Interleukin-6 and interleukin-10 in cerebrospinal fluid after traumatic brain injury in children. J. Neurotrauma 14, 451-457.
12. Bembea, M. M., Savage, W., Strouse, J. J., McElrath Schwartz, J., Graham, E., Thompson, C. B., et al. (2011). Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation. Pediatr. Crit. Care Med. 12, 572-579.
13. Berger, R. P., Adelson, P. D., Pierce, M. C., Dulani, T., Cassidy, L. D., and Kochanek, P. M. (2005). Serum neuron-specific enolase, S100B and myelin basic protein concentrations after inflicted and non-inflicted traumatic brain injury in children. J. Neurosurg. 103, 61-68.
14. Berger, R. P., Adelson, P. D., Richichi, R., and Kochanek, P. M. (2006a). Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury. Dev. Neurosci. 28, 327-335.
15. Berger, R. P., Dulani, T., Adelson, P. D., Leventhal, J. M., Richichi, R., and Kochanek, P. M. (2006b). Identification of brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool. Pediatrics 117, 325-332.
16. Berger, R. P., Hayes, R. L., Richichi, R., Beers, S. R., and Wang, K. K. W. (2012). Serum concentrations of ubiquitin C-terminal hydrolase-L1 and aII-spectrin breakdown product 145kDa correlate with outcome after pediatric TBI. J. Neurotrauma 26, 162-167.
17. Berger, R. P., Janesko-Feldman, K. L., Wisniewski, S. R., Adelson, P. D., Clark, R. S. B., Ruppel, R., et al. (2002). Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109, E31.
18. Berger, R. P., T'asan, S., Rand, A., Lokshin, A., and Kochanek, P. M. (2009). Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury. Pediatr. Res. 65, 97-102.
19. Bhutta, A. T., Schmitz, M. L., Swearingen, C., James, L. P., Wardbegnoche, W. L., Lindquist, D. M., et al. (2012). Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: a pilot randomized, double-blind, placebo-controlled trail. Pediatr. Crit. Care Med. 13, 328-337.
20. Bohmer, J., Kjekshus, J. K., and Vaagenes, P. (1983). Biochemical indices of cerebral ischemic injury. Scand. J. Clin. Lab. Invest. 43, 261-265.
21. Buttram, S. D., Wisniewski, S. R., Jackson, E. K., Adelson, P. D., Janesko-Feldman, K. L., Bayir, H., et al. (2007). Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J. Neurotrauma 24, 1707-1718.
22. Cengiz, P., Zemlan, F., Ellenbogen, R., Hawkins, D., and Zimmerman, J. J. (2008). Cerebrospinal fluid cleaved-tau and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus. Pediatr. Crit. Care Med. 9, 524-529.
23. Clark, R. S. B., Kochanek, P. M., Adelson, P. D., Bell, M. J., Carcillo, J. A., Chen, M., et al. (2000). Increases in Bcl-2 protein in cerebrospinal fluid and evidence for programmed-cell death in infants and children following severe traumatic brain injury. J. Pediatr. 137, 197-204.
24. Clark, R. S. B., Kochanek, P. M., Chen, M., Watkins, S. C., Marion, D. W., Chen, J., et al. (1999). Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J. 13, 813-821.
25. Cooper, D. J., Rosenfeld, J. V., Murray, L., Arabi, Y. M., Davies, A. R., D'Urso, P., et al. (2011). Decompressive craniectomy in diffuse traumatic brain injury. N. Engl. J. Med. 364, 1493-1502.
26. DeKosky, S. T., Ikonomovic, M. D., and Gandy, S. (2010). Traumatic brain injury - football, warfare, and long-term effects. N. Engl. J. Med. 363, 1293-1296.
27. Du, L., Hickey, R. W., Bayir, H., Watkins, S. C., Tyurin, V. A., Gua, F., et al. (2009). Starving neurons show sex difference in autophagy. J. Biol. Chem. 284, 2383-2396.
28. Dubo, H., Park, D., Pennington, R. J. T., Kalbag, R. M., and Walton, J. N. (1967). Serum-creatine-kinase in cases of stroke, head injury, and meningitis. Lancet 2, 743-748.
29. Ennen, C. S., Huisman, T. A., Savage, W. J., Northington, F. J., Jennings, J. M., Everett, A. D., et al. (2011). Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am. J. Obstet. Gynecol. 205, 251.e1-7.
30. Fink, E. L., Berger, R. P., Clark, R. S., Watson, R. S., Angus, D. C., Panigraphy, A., et al. (2011). Serum biomarkers of brain injury predict outcome after pediatric cardiac arrest. Circulation 124, A154.
31. Fink, E. L., Lai, Y., Zhang, X., Janesko-Feldman, K. L., Adelson, P. D., Szabo, C., et al. (2008). Quantification of Poly (ADP-ribose) - modified proteins in cerebrospinal fluid from infants and children after traumatic brain injury. J. Cereb. Blood Flow Metab. 28, 1523-1529.
32. Fraser, D. D., Close, T. E., Rose, K. L., Ward, R., Mehl, M., Farrell, C., et al. (2011). Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum. Pediatr. Crit. Care Med. 12, 319-324.
33. Galloway, N. R., Tong, K. A., Ashwal, S., Oyoyo, U., and Obenaus, A. (2008). Diffusion-weighted imaging improves outcome prediction in pediatric traumatic brain injury. J. Neurotrauma 25, 1153-1162.
34. Gao, W., Chadha, M. S., Berger, R. P., Omenn, G., Allen, D., Pisano, M., et al. (2007). Biomarkers and diagnosis: a gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. J. Neurotrauma 24, 43-53.
35. Gazzolo, D., Michetti, F., Bruschettini, M., Marchese, N., Lituania, M., Mangraviti, S., et al. (2003). Pediatric concentrations of S100B protein in blood: age- and sex- related changes. Clin. Chem. 49, 967-970.
36. Han, Y. Y., Carcillo, J. A., Ruppel, R. A., Adelson, P. D., Wisniewski, S. R., Bell, M. J., et al. (2002). Cerebrospinal fluid procalcitonin is increased after traumatic brain injury in children. Pediatr. Crit. Care Med. 3, 39-44.
37. Hayes, R. L., Jenkins, L. W., and Lyeth, B. G. (1992). Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. J. Neurotrauma 9, 173-187.
38. Hayes, R. L., Mondello, S., and Wang, K. (2011). Glial fibrillary acidic protein: a promising biomarker in pediatric brain injury. Pediatr. Crit. Care Med. 12, 603-604.
39. Hsu, A. A., Fenton, K., Weinstein, S., Carpenter, J., Dalton, H., and Bell, M. J. (2008). Neurological injury makers in children with septic shock. Pediatr. Crit. Care Med. 9, 245-251.
40. Ichord, R. N., Naim, M., Pollock, A. N., Nance, M. L., Margulies, S. S., and Christian, C. W. (2007). Hypoxic-ischemic injury complicates inflacted and accidental traumatic brain injury in young children: the role of diffusion-weighted imaging. J. Neurotrauma 24, 106-118.
41. Jenny, C., Hymel, K. P., Ritzen, A., Reinert, S. E., and Hay, T. C. (1999). Analysis of missed cases of abusive head trauma. JAMA 281, 621-626.
42. Ji, J., Kline, A. E., Amoscato, A., Arias, A. S., Sparvero, L. J., Tyurin, V. A., et al. (2012). Lipidomics identifies cardiolipin oxygenation as a mitochondrial target for redox therapy of brain injury. Nat. Neurosci. 15, 1407-1415.
43. Kagan, V. E., Bayir, H., Belikova, N. A., Kapralov, O., Tyurina, Y. Y., Tyurin, V. A., et al. (2009). Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic. Biol. Med. 46, 1439-1453.
44. Kagan, V. E., Borisenko, G. G., Tyurina, Y. Y., Tyurin, V. A., Jiang, J., Potapovich, A. I., et al. (2004). Oxidative lipidomics of apoptosis: redux catalytic interactions of cytochrome c cardiolipin and phospatidylserine. Free Radic. Biol. Med. 37, 1963-1985.
45. Kjekshus, J. K., Vaagenes, P., and Hetland, O. (1980). Assessment of cerebral injury with spinal fluid creatine kinase (CSF-CK) in patients after cardiac resuscitation. Scand. J. Clin. Lab. Invest. 40, 437-444.
46. Kochanek, P. M., Carney, N., Adelson, P. D., Ashwal, S., Bell, M. J., Bratton, S., et al. (2012a). Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents - second edition. Pediatr. Crit. Care. Med. 13(Suppl. 1), S1-82.
47. Kochanek, P. M., Carney, N., Adelson, P. D., Ashwal, S., Bell, M. J., Bratton, S., et al. (2012b). Chapter 10. Cerebrospinal fluid drainage. Pediatr. Crit. Care Med. 13(Suppl. 1), S46-S48.
48. Kochanek, P. M., Clark, R. S. B., Ruppel, R. A., Adelson, P. D., Bell, M. J., Whalen, M. J., et al. (2000). Biochemical, cellular and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: lessons learned from the bedside. Pediatr. Crit. Care Med. 1, 4-19.
49. Lardner, D., Davidson, A., Mckenzie, I., and Cochrane, A. (2004). Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass. Paediatr. Anaesth. 14, 495-500.
50. Liesemer, K., Bratton, S. L., Zebrack, C. M., Brockmeyer, D., and Statler, K. D. (2011). Early post-traumatic seizures in moderate to severe pediatric traumatic brain injury: rates, risk factors, and clinical features. J. Neurotrauma 28, 755-762.
51. Lindberg, L., Forsell, C., Jogi, P., and Olsson, A. K. (2003). Effects of dexamathasone on clinical course, C-relative protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. Br. J. Anaesth. 90, 728-732.
52. Liu, Y., Xu, Y., Li, D. Z., Shi, Y., and Ye, M. (2009). Comparison of S100B and NSE between cardiac surgery and interventional therapy for children. Pediatr. Cardiol. 30, 893-897.
53. Massaro, A. N., Chang, T., Kadom, N., Tsuchida, T., Scafidi, J., Glass, P., et al. (2012). Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia. J. Pediatr. 161, 434-440.
54. Matheis, G., Abdel-Rahman, U., Braun, S., Wimmer-Greinecker, G., Esmaili, A., Sietz, U., et al. (2000). Uncontrolled reoxygenation by initiating cardiopulmonary bypass is associated with higher protein S100 in cyanotic versus acyanotic patients. Thorac. Cardiovasc. Surg. 48, 263-268.
55. Mehta, A., Kochanek, P. M., Tyler-Kabara, E., Adelson, P. D., Wisniewski, S. R., Berger, R. P., et al. (2010). Relationship of intracranial pressure and cerebral perfusion pressure with outcome in young children after severe brain injury. Dev. Neurosci. 32, 413-419.
56. Pike, B. R., Zhao, X., Newcomb, J. K., Pasmantur, R. M., Wang, K. K., and Hayes, R. L. (1998a). Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport 9, 2437-2442.
57. Pike, B. R., Zhao, X., Newcomb, J. K., Wang, K. K., Posmantur, R. M., and Hayes, R. L. (1998b). Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septo-hippocampal cultures. J. Neurosci. Res. 52, 505-520.
58. Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. L., Heaton, S. C., et al. (2007). Clinical significance of alphall-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366.
59. Portela, L. V., Tort, A. B., Schaf, D. V., Ribeiro, L., Nora, D. B., Walz, R., et al. (2002). The serum S100B concentration is age dependant. Clin. Chem. 48, 950-952.
60. Redl, H., Pelinka, L., Bahrami, S., and Boltzman, L. (2008). To be or not to be - a biomarker of damage in sepsis. Pediatr. Crit. Care Med. 9, 337-339.
61. Reeves, T. M., Philips, L. L., and Povilshock, J. T. (2005). Myelinated and unmyelinated axons of the corpus callosum differ in vulnerability and functional recovery following traumatic brain injury. Exp. Neurol. 196, 126-137.
62. Robertson, C. L., Bell, M. J., Kochanek, P. M., Adelson, P. D., Wisniewski, S. R., Mi, Z., et al. (2001a). Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity. Crit. Care Med. 29, 2287-2293.
63. Robertson, C. L., Minamino, N., Ruppel, R., Kangawa, K., Adelson, P. D., Tsuji, T., et al. (2001b). Increased adrenomedullin in cerebrospinal fluid after traumatic brain injury in infants and children. J. Neurotrauma 18, 861-868.
64. Roka, A., Kelen, D., Halasz, J., Beko, G., Azzopardi, D., and Szabo, M. (2012). Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta. Peadiatr. 101, 319-323.
65. Ruppel, R. A., Kochanek, P. M., Adelson, P. D., Rose, M., Wisniewski, S. R., Bell, M. J., et al. (2001). Excitotoxicity amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. J. Pediatr. 138, 18-25.
66. Sachs, E. Jr. (1957). Acetycholine and serotonin in the spinal fluid. J. Neurosurg. 14, 22-27.
67. Salonia, R., Empey, P. E., Poloyac, S. M., Wisniewski, S. R., Klamerus, M., Ozawa, H., et al. (2010). Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury. J. Neurotrauma 27, 1819-1825.
68. Satchell, M. A., Lai, Y., Kochanek, P. M., Wisniewski, S. R., Fink, E. L., Siedberg, N. A., et al. (2005). Cytochrome C, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. J. Cereb. Blood Flow Metab. 25, 919-927.
69. Scherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., et al. (1999). Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Sci. U.S.A. 96, 8721-8726.
70. Smith, D. H., Hicks, R., and Povilshock, J. (2013). Therapy development for diffuse axonal injury. J. Neurotrauma 30, 307-323.
71. Su, E., Bell, M., Adelson, P. D., Kochanek, P. M., Kagan, V., and Bayir, H. (2010). a Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children. The effect of therapeutic hypothermia. Dev. Neurosci. 32, 385-395.
72. Su, E., Bell, M. J., Kochanek, P. M., Wisniewski, S. R., Bayir, H., Clark, R. S. B., et al. (2012). Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia. Neurocrit. Care 17, 401-407.
73. Tong, K. A., Ashwal, S., Holshouser, B. A., Nickerson, J. P., Wall, C. J., Shutter, L. A., et al. (2004). Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann. Neurol. 65, 36-50.
74. Tower, D. B., and McEachern, D. (1949). Acetylcholine and neuronal activity: I. Cholinesterase patterns and acetylcholine in the cerebrospinal fluids of patients with craniocerebral trauma. Can. J. Res. 27, 105-119.
75. Tyurin, V. A., Tyurina, Y. Y., Kochanek, P. M., Hamilton, R., DeKosky, S. T., Greenberger, J. S., et al. (2008). Oxidative lipidomics of apoptosis: quantitative assessment of phospholipids hydroperoxides in cells and tissues. Meth. Enzymol. 442, 375-393.
76. Vaagenes, P. (1986). Effects of therapeutic hypothermia on activity of some enzymes I cerebrospinal fluid of patients with anoxic-ischemic brain injury. Clin. Chem. 32, 1336-1340.
77. Vaagenes, P., Cantadore, R., Safar, P., Moossy, J., Rao, G., Diven, W., et al. (1984). Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs. Crit. Care. Med. 12, 846-855.
78. Vaagenes, P., Kjekshus, J. K., Sivertsen, E., and Semb, G. (1987). Temporal pattern of enzyme changes in cerebrospinal fluid in patients with neurologic complications after open heart surgery. Crit. Care. Med. 15, 726-731.
79. Vaagenes, P., Kjekshus, J. K., and Torvik, A. (1980). The relationship between cerebrospinal fluid creatine kinase and morphologic changes in the brain after transient cardiac arrest. Circulation 60, 1194-1199.
80. Vaagenes, P., Safar, P., Diven, W., Moossy, J., Rao, G., Cantadore, R., et al. (1988). Brain enzyme levels in CSF after cardiac arrest and resuscitation in dogs: markers of damage and predictors of outcome. J. Cereb. Blood Flow Metab. 8, 262-275.
81. Vaagenes, P., Urdal, P., Melvoll, R., and Valnes, K. (1986). Enzymes level changes in the cerebrospinal fluid of patients with acute stroke. Arch. Neurol. 43, 357-362.
82. Verweij, B. H., Muizelaar, J. P., Vinas, F. C., Peterson, P. L., Xiong, Y., and Lee, C. P. (2000). Impaired cerebral mitochondrial function after traumatic brain injury in humans. J. Neurosurg. 93, 815-820.
83. Whalen, M. J., Carlos, T. M., Kochanek, P. M., Wisniewski, S. R., Bell, M. J., Clark, R. S. B., et al. (2000). Interleukin-8 is increased in CSF of children with severe brain injury. Crit. Care. Med. 28, 929-934.
84. Yakovlev, A. G., Ota, K., Wang, G., Movsesyan, V., Bao, W. L., Yoshihara, K., et al. (2001). Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis. During brain development and after traumatic brain injury. J. Neurosci. 21, 7439-7446.
85. You, Z., Savitz, S. L., Yang, J., Degterev, A., Yuan, J., Cuny, G. D., et al. (2008). Necrostatin-1 reduces histpathology and improves functional outcome after controlled cortical impact in mice. J. Cereb. Blood Flow Metab. 28, 1564-1573.